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Abstract
Background: Tourniquet use in total knee arthroplasty (TKA) surgery is applied to minimize blood loss thereby
creating better overview of the surgical field. This induces ischemia in the skeletal muscle resulting in reperfusion
injury. Our aim was to investigate the in vivo metabolic changes in the skeletal muscle during TKA surgery using
microdialysis (MD).
Methods: Seventy patients were randomly allocated to tourniquet group (n = 35) or non-tourniquet group (n = 35).
Prior to surgery, catheters were inserted in the operated leg and non-operated leg. Interstitial dialysate was collected
before and after surgery and at 20 min intervals during a 5 h reperfusion period. Main variables were ischemic
metabolites: glucose, pyruvate, lactate and glycerol and L/P ratio.
Results: Significant difference in all metabolites was detected between the two groups, caused by tourniquet
application. Tourniquet induced ischemia resulted in decreased levels of glucose and pyruvate to 54 and 60 %
respectively, compared to baseline. Simultaneously, accumulation of lactate to 116 % and glycerol to 190 % was
observed. L/P ratio was elevated indicating ischemia.
In the non-tourniquet group the metabolite changes were less profound and normalized within 60 min.
Conclusions: Microdialysis revealed that performing TKA with tourniquet is associated with increased ischemia.
This affects all metabolites but the changes are normalized after 5 h
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Background
In elective TKA the intraoperative use of pneumatic
tourniquet is commonly used to minimize blood loss
and enhance surgical overview. Despite knowing, that
tourniquet induces ischemia and soft tissue damage
surgeons still uses it, often not aware of the effects of
the induced ischemia [1].
The kinetics of ischemic metabolites during periods of
ischemia and reperfusion remains uncertain. The tourni-
quet pressure combined with ischemia has been investi-
gated and inflicts a more profound damage to the
skeletal muscle than ischemia alone [2]. The clinical
aspects regarding tourniquet use has been vigorously
investigated and cases of rhabdomyolysis have been
described [1, 3–6].
The skeletal muscle in limbs is very sensitive to ischemic
changes and a clinical assessment is not sufficient to
evaluate the degree of ischemic tissue damage induced
by the tourniquet [7, 8]. Thus, using an in vivo tech-
nique could provide a more accurate assessment of the
metabolic events.
Microdialysis (MD) is a minimally invasive technique
that allows continuous in vivo monitoring of metabolism
in extracellular space [9]. It was originally described by
Ungersted and Pycock to monitor neurochemical changes
[10]. Interstitial levels of metabolites as glucose, lactate,
pyruvate, lactate/pyruvate (L/P) ratio were measured, be-
cause they serve as direct indicators of ischemia, whereas
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glycerol reflects cell damage [8, 11, 12]. During ischemia,
lactate increases and pyruvate decreases, leading to an
increased L/P ratio, where a ratio above 25 is considered
abnormal [13]. Lactate/pyruvate ratio was calculated since
it is a precise marker of ischemia and increase during
ischemia [14].
The microdialysis catheter consists of a double-lumen
linear tube that at the tip has a semipermeable mem-
brane, the tube mimics the functions of a capillary blood
vessel. The catheter is connected to a pump that, with a
constant flow, pumps the fluid so it can pass the mem-
brane. Diffusion along the concentration gradient occurs
in the interstitial space and equilibrium takes place
between the fluid and molecules. The molecules are
collected in small vials, which reflects the composition
of the interstitial space fluid and can then be analyzed im-
mediately afterwards. The metabolites of interests have
traditionally been pyruvate, glucose, lactate and glycerol.
To our knowledge MD technique has not been applied
in a randomized controlled setup to investigate tourni-
quet induced ischemia during TKA surgery, even though
this could contribute to the understanding of the
phenomenon.
The aim of this study was to investigate the in vivo
degree of ischemia in skeletal muscle with the use of
MD during surgery and cuff inflation and during a
period of reperfusion to estimate ischemia and cell dam-
age. In particular the limb distally to the cuff was of par-
ticular interest and not directly beneath the cuff, where
apparent ischemia takes place.
Methods
This prospective randomized clinical trial was conducted
at Aalborg University Hospital, Aalborg, Denmark. A total
of 70 primary TKA were performed between January 2011
and January 2012.
Approval from the local Ethics Committee (approval
no. N-20090045) and registration at ClinicalTrials.gov
(NCT01309035) were obtained. All patients gave written
consent and were enrolled in this study in accordance
with the Consolidated Standards of Reporting Trials
(CONSORT) and The Helsinki Declaration (Fig. 1).
This study was part of a larger randomized controlled
trial where two other main aims were investigated: tour-
niquets effect on implant fixation and clinical outcomes.
The ischemic conditions of tourniquet use are presented
in this publication.
Patients
Patients aged 50–85 scheduled for primary unilateral
TKA were included and were comparable regarding demo-
graphics (Table 1). Exclusion criteria included rheumatoid
arthritis, peripheral vascular disease, diabetes, prior knee
surgery and use of anticoagulation medicine.
Patients were block randomized using sealed envelopes
and were allocated into two groups: 34 patients had
surgery using a tourniquet (Tq group) and 33 patients
had surgery without the use of a tourniquet (non-Tq
group). The envelopes were opened when the surgeon
was present in the operating theatre before surgery.
Patients were unaware of the group to which they had
been allocated.
Microdialysis
In this study we used CMA 60 (CMA Microdialysis AB,
Sweden) catheters (length 30 mm, outer diameter 0.6 mm
and molecular cut off 20 kDa) in skeletal muscle of the
lower extremity. In both groups 2–3 ml lidocaine was
injected subcutaneously in the gastrocnemius muscles
(vastus medialis) before catheters were inserted parallel to
the muscle fibers at an angle of 35°. The correct position
of the catheter was verified by ultrasonography. In the
non operated leg a catheter was inserted at same level,
serving as a reference.
Catheters were connected to a syringe filled with 4 ml
perfusion fluid T1 (CMA Microdialysis AB, Sweden)
that was placed in CMA 106 MD pumps, that were con-
stant perfused at a rate 0.3 μl/min. Afterwards a period
of 40 min of flushing and stabilization was allowed.
The ISCUS MD analyzer (CMA Microdialysis AB,
Sweden) with Reagent Set A was used to analyze all the
collected MD samples and this was done immediately
after sampling.
Before surgery, MD catheters were inserted and the
average of the first consecutive samples before perform-
ing surgery, were used to establish a baseline and
defined as 100 % for metabolites (Table 2). Baseline was
measured, after an initial 40 min flushing period
followed by a stabilization period of 20 min. In the refer-
ence leg, baseline reached stable values within that
period of time, and remained unchanged for the whole
period of 300 min.
Immediately after surgery and tourniquet release if
that was used, the first sample was collected which
defined the time zero (t = 0). The dialysates were regu-
larly collected every 20 min during a 5 h postoperative
period, representing time of reperfusion. Samples from
each patient were obtained and the changes in the oper-
ated leg was compared to the baseline and the patient’s
own reference leg. In addition, the non-tq group served as
a reference group. Differences between the two groups
were compared to evaluate tourniquet effects.
Longer periods of ischemia leave the cells depleted of
energy and the ability to regenerate metabolites decreases.
The skeletal muscle must change from oxidative phos-
phorylation to anaerobic glycolysis to create energy
and maintain homeostasis. Thus, a rise is seen in lac-
tate production and decrease in glucose and pyruvate
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[15]. Glycerol is mainly derived from the degradation
of phospholipids in cell membrane and increases due
to cell damage.
The ratio between the concentration of a metabolite
in a dialysate and interstitial space is expressed as
“relative recovery”. Recovery of a given dialysate is
affected by numerous factors such as molecular
weight, surface area of membrane (length and diameter),
perfusion flow rate, diffusion rate [9, 16]. Previous
studies have described that relative recovery is
inversely related to perfusion flow rate, i.e at a slow
rate of nearly zero (0.33 μl/min) the relative recovery
will be approaching 100 % [9]. The metabolite recov-
ery in present study was defined as 100 %, as relative
recovery was not investigated. In the literature most
of the experiments are performed with incomplete
recovery [8, 12, 15].
Fig. 1 Flow chart of included participants
Table 1 Demographics and perioperative data
Tourniquet (n = 31) Non tourniquet (n = 31)
Mean SD Mean SD
Age (yrs) 68,3 8.4 68.2 7.8
Sex m/f 16/15 17/14
BMI 25.1 2.0 25.2 2.5
Operation time (min) 69.5 5.3 71.3 4.5
Cuff pressure mmHg) 250
Ischemia duration (min) 74.4 3.7
Table 2 Average interstitial baseline concentration at a constant
flow rate of 0.3 μl/min
Glucose (mmol/L) 5.0 ± 2.0
Pyruvate (μmol/L) 64.9 ± 10.4
Lactate (mmol/L) 1.8 ± 0.4
Glycerol (μmol/L) 84.5 +/12.6
L/P ratio 28.3 ± 3
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Surgical technique
All procedures were standardized with regard to spinal
anesthesia, operative technique and postoperative pain
treatment and rehabilitation regimen.
Both groups had an appropriately sized thigh tourni-
quet applied, but it was only inflated in Tq group. In the
non-Tq group, it was placed on the thigh but not in-
flated, thereby serving as a safety device if uncontrollable
bleeding should occur. In Tq group limb exsanguination
was done by elevation for 2 min, the cuff was inflated to
250 mmHg. The cuff was not removed until the wound
was closed and dressed.
All knee implants were the NexGen® CR-Flex Fixed
Bearing Knee (Zimmer, Warsaw, Indiana, USA) with use
of Biomet Refobacin® Bone Cement R (Biomet, Warsaw,
Indiana, USA). In all cases, the patella was resurfaced. Sur-
gical procedures were all performed by the same surgeon.
A two-stage cementation procedure was performed. The
tibia and patella were implanted first, and then another
package of cement was used to fixate the femoral compo-
nent. This procedure, although more time consuming,
was done to secure a careful cementation. Immediately
after wound closure, dressings were applied, and the cuff
was deflated in the Tq group and removed.
Statistical analysis
Data for each metabolite over time in each group were
analyzed by using analysis of variance (ANOVA), Student’s
t-test for comparison of the Tq group with the non-Tq
group, and Wilcoxon rank sum test if assumption for t-test
was not fulfilled. Data is presented as mean and standard
deviation for normal distributed data. The metabolic
changes during surgery and reperfusion are expressed in
percentages of baseline values.
The level of significance was set at 95 % confidence limit
and P-value less than 0.05 was considered significant. Stat-
istical analysis was performed by using STATA 11.0
Results
Seventy patients were enrolled in the trial: 62 patients
(33 male and 29 female) completed the study (Fig 1).
Preoperative demographics were similar between groups
and showed no significant differences regarding age,
weight or gender. The duration of ischemia was 74.4 ±
3.7 min in the tourniquet group.
Comparison between Tq group and non-Tq group
Comparing the Tq group with non-Tq group differences
were registered in all of the metabolites from beginning
of reperfusion time and until a period of 180 min. After
that there were no difference and the metabolites were
restored back to initial levels.
This is expressed in Fig. 2 where the mean differences
between the two groups are shown.
Tourniquet group
All metabolite concentrations were affected following
tourniquet induced ischemia (Fig. 3).
Glucose decreased by 54 % (2.3 ± 0.7 mmol/L; p < 0.001)
and this reduction was detectable during time of reperfu-
sion, but restored back to baseline 300 min postoperatively.
Pyruvate concentration was initially reduced to 60 %
(25.9 ± 5.6 μmol/L; p < 0.001), while it was dramatically
elevated during first period of 30–60 min of reperfusion
to 123 % (145.6+/10.9 μmol/L; p < 0.001). At 180 min it
was restored back to baseline and no difference was
detected (p = 0.118).
Concentration of lactate increased significantly during
reperfusion of 30–60 min up to 116 % (3.9 ± 0.8 mmol/L;
p < 0.001). After 120 min of reperfusion it slowly returned
to baseline (p = 0.129). After 300 min no significant
difference was registered (p = 0.952) when comparing
to baseline (Fig. 3).
Concentration of glycerol also increased dramatically at
beginning of reperfusion to 190 % (244.7 ± 12.5 μmol/L;
p < 0.001) and stayed significant increased during 180 min
of reperfusion (p < 0.001). At 300 min there was no signifi-
cant difference (p = 0.634).
L/P ratio increased significantly 79 % (107 ± 33.3;
p < 0.001) after period of ischemia, but after 90 min
of reperfusion initial level was restored.
Significant differences in all metabolites were noted
until 180 min. between operated leg and non operated
leg (Fig. 4).
All values returned to baseline values within 300 min
in both legs and no difference was registered.
Non-tourniquet group (non ischemic reference group)
The metabolites were less affected an returned faster
back to initial levels (Fig. 5).
The first sample after surgery showed a glucose con-
centration that only decreased 11.5 % (4.6 ± 0.7 mmol/L;
p < 0.001) during surgery and during 90 min of reperfu-
sion normal levels were reached (p = 0.220).
Pyruvate concentration was reduced to 13.5 % (53.8 ±
9.5 μmol/L) of the initial value and during a short reper-
fusion period of 30 min, it was back to baseline.
Concentration of lactate increased during early reper-
fusion and at 30 min it reached a maximum of 30 %
(2.6 ± 0.5 mmol/L). After 60 min. it was unaltered and
no statistical significance was registered.
Glycerol concentration was increased to maximum of
48 % (114.5 ± 15.4. μmol/L) 60 min postoperatively.
During a longer postoperative period it slowly returned
to normal (Fig. 5).
L/P ratio also changed significantly reaching maximum
at 30 min reperfusion, 45 % (42.2 ± 13.3; p < 0.001) but
after this time of it was quickly restored. Difference
between operated and non operated leg did not show
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greater ischemic conditions, rather cell damage as a
response to surgery was registered, expressed as increase
in glycerol (Fig. 6)
Discussion
Microdialysis is recognized as a useful tool when asses-
sing metabolic changes in skeletal tissue in clinical set-
tings [8, 15]. The present study establishes microdialysis
as an effective way to monitor interstitial levels of me-
tabolites during tourniquet induced ischemia. The study
was conducted to investigate metabolic changes distally
in a limb, since the ischemia underneath the tourniquet
has been described previously in literature [15]. The
period of interest was when the limb was exposed to
ischemia during surgery and the following time of reper-
fusion. The main findings showed that tourniquet use
Fig. 2 Tourniquet use induces significant ischemia and differences between the Tq group and the non-Tq group are detected in all of the metabolites
from the beginning of reperfusion and until 180 min
Fig. 3 Tq group: absolute values in percentile change from baseline. The ischemic changes are normalized after 300 min
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causes ischemia and cell damage as measured by metab-
olites. Significant ischemia can be detected in the af-
fected limb until 3 h because of tourniquet use. All
Marker levels were normalized after 5 h.
To our knowledge, this study is the first to assess the
ischemic changes during TKA surgery caused by tourni-
quet use in a randomized setup.
The difference between the two groups illustrate
that tourniquet application induces changes in level of
metabolic markers, which are manifested up to 180 min
of reperfusion.
The systemic response to surgery observed in the
markers was adjusted for, by using the non-tourniquet
group as reference and we concluded that the differ-
ences in marker levels are locally affected by the tourni-
quet induced ischemia.
In the tourniquet group there were significant changes
of all the metabolites in the operated leg, when comparing
Fig. 4 Mean difference between operated leg and reference leg in the Tq group. Significant differences in metabolites are detected until 180 min
Fig. 5 In the non-Tq group metabolite changes were smaller and restored within 60 min
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baseline to measurements during reperfusion. The differ-
ences were present in all metabolites and were statistically
significant comparing from baseline during reperfusion,
before slowly returning to normal levels. The non-operated
leg, that served as indicator for systemic response, was
compared to the operated leg and significant difference
were also present at the individual measurement points.
The difference between the operated leg and non operated
leg represents the local skeletal muscle response in the
operated leg.
In the non-tourniquet group, levels of metabolites had
changed in the operated leg when comparing baseline to
postoperative measurements, but they returned to base-
line values faster. Changes were similar to tourniquet
group, but not as large or prolonged. When comparing
the operated leg and reference leg there was no signifi-
cant difference, indicating that a local response is not
occurring and that the changes are due to an overall
systemic response to surgery (Fig. 5).
Thigh pain and swelling has been investigated in other
studies, finding tourniquet application being the reason
for increased pain and swelling due to ischemia and
direct compression [4, 17].
Little is known about basal metabolite concentrations in
interstial levels of resting skeletal muscle. Comparing to
previous studies our baseline levels are in agreement with
data reported earlier [8, 12, 15]. In these studies baseline
levels ranged from 3.3–5 mmol/L for glucose, between
1.9 –2.4 mmol/l for lactate, between 40–96 μmol/L for
glycerol, while pyruvate was only measured in one
study at levels of around 40 μmol/L [15].
Östman et al. [15] used microdialysis to measure tour-
niquet induced ischemia in patients undergoing arthro-
scopic surgery. Here measurements were carried out
over a time course of 120 min after tourniquet release.
All the metabolites were affected and within 120 min
the changes were restored back to normal values. The
results are in consistence with this present study, where
the same metabolite kinetics was observed.
Glycerol is a component of the cell plasma membrane
and released into the interstitial space when cells are
damaged during surgery. Glycerol can be used as a
marker of cell destruction. In addition, high levels of
glycerol may also be due to the hormonal regulation of
lipolysis and hypoglycemia during tourniquet use which
facilitates a catecholamine response that initiate a lipoly-
sis reaction in skeletal muscle [17]. This can partially be
a reason for the high rise in glycerol concentration in
the tourniquet group, combined with the mechanical
compression of the tourniquet.
Increased L/P ratio is a precise marker of ischemia
and we observed a difference from baseline immediately
after surgery when using tourniquet. After a period of
60 min reperfusion L/P ratio levels were back to normal.
In the non-Tq group no difference was observed.
Muscles are believed to be relatively resistant to ische-
mia, but even shorter or sudden periods of ischemia
may result in an overload of calcium in the muscle and
could in weaker patients induce secondary complications
such as compartment syndrome and respiratory distress
syndrome [8, 13]. This should be taken into consider-
ation if tourniquets are applied.
Fig. 6 Mean difference in the non-Tq group between operated leg and reference leg. Glycerol is affected due to cell damage as response to surgery.
Ischemic metabolites are not affected
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Microdialysis is a minimally invasive technique that has
limited risks for patients and even with small concentra-
tion volumes, monitoring of the ischemic changes is
allowed. It is applicable despite reduced blood flow during
ischemia and a continuous sampling of interstitial fluids
can be performed. Microdialysis contains a major limita-
tion when estimating data because only an approximation
can be stated. Recovery depends upon many factors that
affect the equilibrium. To achieve the highest recovery we
used the largest membrane recommend to skeletal tissue
and the lowest perfusion rate allowed. Most of the clinical
studies available use relative recovery and by using very
low flow the recovery will be reaching nearly 100 %.
Conclusions
This study shows that using tourniquet in TKA surgery is
associated with increased ischemia during first the postop-
erative hours but the changes are normalized after 5 h.
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